iBIO - Illinois Biotechnology Industry Organization

09/20/2022 | Press release | Distributed by Public on 09/20/2022 10:10

iBIO Members Save: Precision Oncology and Diagnostics Conference

iBIO Members Save: Precision Oncology and Diagnostics Conference

by John Conrad| Sep 20, 2022| Community News

*|MC:SUBJECT|**|MC_PREVIEW_TEXT|*
View this email in your browser
Precision Oncology and Diagnostics
GenomeWeb and the Precision Medicine Leaders' Summit invite you to the Precision Oncology and Diagnostics conference October 19 - 20, 2022 at the Willis Tower in Chicago.

Join oncologists, researchers, and thought leaders from leading cancer centers, pharmaceutical companies, and research institutes who will discuss the latest advances in implementing molecularly guided cancer care
Topics of discussion include:

Liquid Biopsy
Minimal Residual Disease (MRD)
Immuno-oncology
Molecular Tumor Boards
Combination Therapies
Early Detection of Cancer
Oncology Clinical Trials
Clinical Data in the Era of Precision Oncology

Biomarker/Genetics/Genomics Platforms
Clinical Decision Support
NGS for Oncology
Novel Therapies for Cancer
Pediatric Cancer
Antibody Drug Conjugates
Oncology Drug Development
You may view the full agenda here.
Register Now!
Featured Speakers:

Peter Bach, MD
Chief Medical Officer
Delfi Diagnostics

Omar Perez, MD
Head of Medical Diagnostics
US Medical Affairs Oncology
AstraZeneca

Sarah Warren, MD
Senior Director
Research Technology and Business Development Planning
Kite Pharma
Don't miss out on the IBIO discounted rate of 25%!

Early Bird Rates:
General Attendee: $520 (Regular Rate: $695)
Academic/Government/Non-Profit: $445 (Regular Rate: $595)
Resident/Student: $295 (Regular Rate: $395)

Use code "IBIO25" to receive an additional 25% off of the lowest registration rate!
Register Now!
Thank you to our partners and sponsors:
Questions regarding the conference? Contact Deanna Russell

Interested in sponsoring the event? Contact Nigel Russell
Copyright © Crain Communications, All rights reserved.


This email was sent to *|EMAIL|*
why did I get this?unsubscribe from this listupdate subscription preferences
*|LIST:ADDRESSLINE|*